The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

13 Jul 2009 07:00

RNS Number : 5280V
Huntsworth PLC
13 July 2009
 



13 July 2009

Huntsworth plc

Acquisition of Tonic Life Communications Limited

Huntsworth PLC ("Huntsworth"), the international public relations and healthcare communications group, announces today that it has acquired the entire issued share capital of Tonic Life Communications Limited ("Tonic"), a leading healthcare public relations company operating in the UK and USA. This acquisition significantly expands the Huntsworth Health PR operations in the UK and adds to the existing PR division of Dorland in the USA. 

Tonic is a high profile healthcare PR company with its prominence exhibited by presence in the Sunday Times Virgin Fast Track 100, The Holmes Report: World's Fastest Growing PR Agency (2008) and PR Week League Table: 'Star Agencies' 08.

Tonic has been built up by Scott ClarkOliver Parsons and Moira Gitsham all of whom will continue to develop the Tonic business, with Scott and Oliver taking a leadership role in Huntsworth Health's global PR operations. The Tonic Board will report directly to David Rowley, Group CEO of Huntsworth Health. 

Tonic has been acquired from Scott Clark, Oliver Parsons, Moira Gitsham and one other shareholder. The initial consideration is £3.0 million, paid in cash. Deferred consideration may be payable, with an interim payment based on the profits for the two years to 30 June 2011 and a final payment based on the profits for the four years to 30 June 2013.

Payments of deferred consideration are conditional, inter alia, upon profit growth and may be satisfied by cash or loan notes or up to 50% in Huntsworth shares, at the option of Huntsworth. By way of illustration, the maximum total consideration of approximately £12.5 million would require profit growth of over 40% per annum over the 2009 base. 

For the year ended 31 December 2008 Tonic had consolidated revenues of £3.3 million and profit before tax of £0.6 million. The consolidated gross assets at 31 December 2008 were £2.3 million. The business will be acquired with £0.5 million of net cash. 

David Rowley, Chief Executive of Huntsworth Health, commented:

"Huntsworth Health has been tracking the growth of Tonic for some time, and we are delighted that they have agreed to join our group. Scott and Oliver will take a leadership role and augment our current European and US practices. Tonic and its management will significantly increase our reach and expertise in the healthcare public relations arena.

We are extremely pleased to have attracted this leading agency in healthcare PR which will expand the quality services that we offer to the pharmaceutical sector. Tonic's excellent client base and successful management team will complement and strengthen both our science and lifestyle healthcare communications brands."

Scott Clark, Chief Executive of Tonic, said:

"Today's announcement will propel the Tonic brand to an entirely new level and we are looking forward to becoming part of Huntsworth, a group that has grown from strength to strength. This fulfils our strategy to offer compelling new opportunities for our team and clients, allowing us to retain our vision, culture and aspirations while also benefiting from the scope and energy of an emerging global player in the communications industry."

Sally Withey, Group Chief Operating Officer, commented:

"We believe that the acquisition of Tonic will further strengthen our Huntsworth Health offer which now constitutes approximately 27% of Group revenues. The Group expects to meet management's profit expectations in the first half of this year and with 86% of forecast revenues committed for 2009, we remain confident in respect of our full year result."

For further information, please contact:

Huntsworth plc
 
Lord Chadlington, Group Chief Executive
Tel: + 44 20 7224 8778
Sally Withey, Group Chief Operating Officer
Tel: + 44 7899 961 667
David Rowley, Huntsworth Health Chief Executive
Tel: + 44 1628 483196
 
 
Tonic Life Communications Limited
 
Scott Clark, Chief Executive
Tel: +44 20 7798 9901
Oliver Parsons, Managing Director
Tel: +44 20 7798 9902
 
 
Citigate Dewe Rogerson
 
Simon Rigby
Tel: + 44 20 7638 9571

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQVBLFFKDBFBBV
Date   Source Headline
30th Apr 20203:30 pmRNSForm 8.3 - HNT LN
30th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
30th Apr 20202:58 pmRNSHolding(s) in Company
30th Apr 20202:49 pmRNSCourt Sanction of the Scheme
30th Apr 20202:12 pmRNSHolding(s) in Company
30th Apr 202012:37 pmRNSHolding(s) in Company
30th Apr 202010:55 amRNSForm 8.5 (EPT/RI)
30th Apr 202010:05 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
30th Apr 20207:00 amRNSDISCLOSURE BY PERSON WITH INTERESTS IN SECURITIES
29th Apr 20204:28 pmRNSHolding(s) in Company
29th Apr 20203:30 pmRNSForm 8.3 - HNT LN
29th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
29th Apr 202011:02 amRNSForm 8.5 (EPT/RI)
29th Apr 20209:41 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
29th Apr 20208:37 amRNSHolding(s) in Company
28th Apr 20204:53 pmRNSRule 2.9 Announcement
28th Apr 20203:30 pmRNSForm 8.3 - HNT LN
28th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
28th Apr 202010:46 amRNSForm 8.5 (EPT/RI)
28th Apr 202010:35 amRNSForm 8.3 - HUNTSWORTH PLC
28th Apr 20209:21 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
27th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
27th Apr 20209:50 amRNSHolding(s) in Company
27th Apr 20209:02 amBUSForm 8.5 (EPT/NON-RI) - Huntsworth plc
24th Apr 20205:30 pmRNSHuntsworth
24th Apr 20203:30 pmRNSForm 8.3 - HNT LN
24th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
24th Apr 202011:04 amRNSForm 8.5 (EPT/RI)
24th Apr 20209:24 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
24th Apr 20209:21 amRNSForm 8.5 (EPT/RI) - Huntsworth plc
23rd Apr 20203:30 pmRNSForm 8.3 - HNT LN
23rd Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
23rd Apr 202012:18 pmRNSForm 8.3 - Huntsworth Plc
23rd Apr 202010:05 amBUSForm 8.5 (EPT/NON-RI) - Huntsworth plc
23rd Apr 20207:00 amRNSHolding(s) in Company
22nd Apr 20203:20 pmRNSForm 8.3 - Huntsworth plc
22nd Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
22nd Apr 202011:37 amRNSForm 8.3 - Huntsworth plc
22nd Apr 202010:44 amRNSForm 8.5 (EPT/RI)
22nd Apr 202010:33 amBUSFORM 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
22nd Apr 20209:19 amRNSForm 8.5 (EPT/RI) - Huntsworth plc
22nd Apr 20208:53 amRNSHolding(s) in Company
21st Apr 20205:15 pmRNSForm 8.5 (EPT/RI)
21st Apr 20205:10 pmRNSForm 8.5 (EPT/RI)
21st Apr 20204:14 pmRNSOffer update: Antitrust clearance
21st Apr 20203:20 pmRNSForm 8.3 - Huntsworth plc
21st Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
21st Apr 20202:38 pmRNSForm 8.3 - Huntsworth plc
21st Apr 202012:13 pmRNSForm 8.3 - Huntsworth Plc
21st Apr 202011:53 amRNSForm 8.3 - Huntsworth Plc - AMENDMENT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.